Ajanta Pharma Limited Company Profile

Company Overview:

Ajanta Pharma focuses on developing and commercialization of pharmaceutical and related activities. The company's products are sold in over 30 countries. The company has operations in India, Mauritius, the US, the UK, Philippines, and Nigeria.

The company classifies its business as Branded Generic, Generic and Instituions.

Ajanta Pharma develops and commercializes a range of generic products under various brands in various therapeutic areas such as anti-biotic, anti-malarial, anti-diabetic, gynaecology, paediatric, cardiology, dermatology, pain management, ophthalmology and others. The company provides various products for anti-malarial therapeutic area, with a combination of Artemether+Lumenfantrine.

Ajanta Pharma operates six manufacturing facilities in India and one manufacturing facility in Mauritius. The manufacturing capabilities include a range of dosage formulations of allopathic drugs including tablets, capsules, ointments, sterile opthalmic liquids, injectibles and powders. The company's manufactures multivitamins, antibiotics, eye drops, cough syrups, among other.

Ajanta Pharma exports its products across Africa, Asia, Latin America and The Commonwealth of Independent States (CIS).

The company's subsidiaries include Ajanta Pharma (Mauritius) Ltd., Ajanta Pharma Nigeria Ltd, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma UK Ltd.

Scope of the Report

• About the Company - Historical Details, Current Ownership Structure and basic overview of Ajanta Pharma Limited in terms of revenue, net income, and operating income.
• Financials - Details about Ajanta Pharma Limited listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
• Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
• Company SWOT Analysis - Outlines Ajanta Pharma Limited’s strengths, weaknesses, and opportunities and threats facing the company.
• Recent Developments - Showcases Ajanta Pharma Limited’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
• Strategic Evaluation - Provides an overview of Ajanta Pharma Limited’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
• Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.

Key Questions Answered

• What domain does Ajanta Pharma Limited operate and what are key points about it?
• What is the product / service portfolio of Ajanta Pharma Limited?
• How has Ajanta Pharma Limited performed financially from the 2013?
• How does Ajanta Pharma Limited rank among its peers in terms of revenue and market share?
• What are Ajanta Pharma Limited strengths and weaknesses and what opportunities and threats does it face?
• What are Ajanta Pharma Limited’s main growth strategies and how successful has the company been at implementing them?
• What is the in-house technical capability of Ajanta Pharma Limited? Where does it procure / outsource it?

Reasons to buy

• Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
• Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
• 12 hour delivery time fulfilling your urgent requests as per your requirement
• On-demand customization options that can completely cater to your needs by focusing the report onto given specifics